(Q73179856)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1 reference

D Strohmeyer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Rössing

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Bauerfeind

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

O Kaufmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H Schlechte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Bartsch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Loening

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

216-224

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Signaling angiogenesis and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

21 January 2018

Molecular angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Quantitative microvessel density. A staging and prognostic marker for human prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Vascular density is a predictor of cancer-specific survival in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Rapid screening for Tp53 mutations by temperature gradient gel electrophoresis: a comparison with SSCP analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Angiogenic peptides in prostatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: an in vitro model for assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Infrequent RAS oncogene mutations in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Comparison of ras activation in prostate carcinoma in Japanese and American men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820001101%2945%3A3%3C216%3A%3AAID-PROS3%3E3.0.CO%3B2-C

10.1002/1097-0045(20001101)45:3<216::AID-PROS3>3.0.CO;2-C

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11074523%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference